Trials / Conditions / Neovascular Age-related Macular Degeneration (NVAMD)
Neovascular Age-related Macular Degeneration (NVAMD)
3 registered clinical trials studyying Neovascular Age-related Macular Degeneration (NVAMD) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO NCT07205887 | EyeBiotech Ltd. | Phase 2 |
| Active Not Recruiting | A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Followi NCT06664502 | EyeBiotech Ltd. | Phase 1 / Phase 2 |
| Completed | A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to As NCT05919693 | EyeBiotech Ltd. | Phase 1 / Phase 2 |